The Daily Telegraph

‘Revolution­ary’ eczema treatment passes trials


A drug therapy to treat moderate to severe eczema in young children has been shown to be “safe and highly effective” in clinical trials.

In an internatio­nal study, published in the journal The Lancet, dupilumab was shown to reduce the severity of the skin condition within two weeks in patients aged six months to six years.

The children and their parents also reported improved sleep and quality of life. Doctors believe the treatment may be approved for children under the age of six in the UK soon. It is already licensed for those aged six to 18.

Dr Peter Arkwright, of the University of Manchester, said: “It will revolution­ise clinical practice.”

Newspapers in English

Newspapers from United Kingdom